Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer Clinical Trials

Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer

Explore clinical trials studying Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer trial results

Completed

A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02838420

Conditions: Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Locations: Beijing Cancer Hospital Beijing, China

Beijing Chest Hospital Beijing, China

the First Hospital of Jilin University Changchun, China

West China Hospital, Sichuan University Chengdu, China

View all 19 locations

View Trial Details